PTC Therapeutics | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
Acadia Pharmaceuticals 0 4.12M 2024-09
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Cytokinetics USD 22.59M 296K 2024-12
Daiichi Sankyo 11.62B 11.42B 2024-09
Gilead Sciences USD 260M 12M 2025-03
Incyte USD 419K 355K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Novartis USD 275M 11M 2024-12
Pfizer USD 739M 45M 2024-12
PTC Therapeutics USD 43.35M 1.24M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
TG Therapeutics USD 10.83M 6.86M 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Xencor -39359000 40.15M 2024-12



PTC Therapeutics Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.